Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Alternative Laboratories
WARNING LETTER
•Alternative Laboratories•June 10, 2019

FDA WARNING_LETTER - Alternative Laboratories - June 10, 2019

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Alternative Laboratories
Record Details

The FDA issued a Warning Letter to a dietary supplement manufacturer in Naples, FL, following an inspection from May 29-31, June 3, and June 10, 2019. The letter addresses violations concerning several products, including Elevate Smart Coffee, Choclevate, Elevate Nitro, Revital U Smart Coffee, Valentus SlimRoast Optimum Dark Roast Coffee, and Valentus SlimRoast Optimum Cocoa.

The primary violation involves the declared ingredient 2-amino-5 methylheptane and Octodrine (DMHA). The FDA states that DMHA is a "new dietary ingredient" for which no pre-market notification was submitted, rendering the products adulterated under sections 402(f) and 413(a) of the Federal Food, Drug, and Cosmetic Act (the Act). The FDA also notes a lack of evidence establishing DMHA's safety as a dietary ingredient. Furthermore, if DMHA is not a dietary ingredient, it would be considered an unsafe food additive, leading to adulteration under section 402(a)(2)(C)(i) of the Act.

Additionally, the "CBD oil" (550mg) distributed under the "Green Roads" brand is labeled as a dietary supplement but does not meet the definition, as CBD is an active ingredient in an approved drug product (Epidiolex) and has been authorized for investigation as a new drug,

Company
Alternative Laboratories
Inspection Date
June 10, 2019
Product Type
Food
Office
Office of Human and Animal Food Operations East Division IV
People
  • Laura Kennedy (Regulatory Officer)
  • Ramon A. Hernandez (Program Director)
Open in Dashboard

ID · 63fe1583-a286-4e66-b0a9-2c983c859060

Violation Codes10
21 U.S.C. 331(a)21 U.S.C. 321(ff)21 U.S.C. 321(ff)(1)21 U.S.C. 350b(d)21 U.S.C. 350b21 U.S.C. 342(f)21 U.S.C. 350b(a)(2)21 CFR 190.621 U.S.C. 331(v)21 U.S.C. 342(a)(C)(i)

Full citation text and observation details available on the Dashboard.

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.